PHARMACOKINETIC BASIS OF INTRAVENOUS DRUG DELIVERY

被引:5
|
作者
GLASS, PSA
DOHERTY, D
JACOBS, JR
QUILL, TJ
机构
来源
BAILLIERES CLINICAL ANAESTHESIOLOGY | 1991年 / 5卷 / 03期
关键词
D O I
10.1016/S0950-3501(05)80050-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have seen in recent years the release of numerous intravenous anaesthetic agents whose duration of action is relatively short, thus lending themselves to administration via continuous infusion. Clinical studies have clearly demonstrated the advantages of continuous infusion over repeated bolus dosing. These two factors have prompted pump manufacturers to produce devices that simplify the administration of intravenous anaesthetics by continuous infusion. It is concentration rather than dose that results in the desired effect. Utilizing pharmacokinetic principles, it is possible to provide automated drug delivery systems whereby the device can produce a clinician-specified drug concentration. In addition, where there is an easily measurable end-point, closed-loop feedback control can be implemented automatically to control the desired parameter within a very narrow range. With this rapid development in intravenous drug delivery, it becomes imperative that clinicians familiarize themselves with these new drug delivery devices so that they can use them optimally to care for their patients. © 1991 Baillière Tindall.
引用
收藏
页码:735 / 775
页数:41
相关论文
共 50 条
  • [31] EFFECT OF IV DRUG DELIVERY SYSTEMS ON PHARMACOKINETIC MONITORING
    NAHATA, MC
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1987, 44 (11): : 2538 - 2542
  • [32] Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
    Wijagkanalan, Wassana
    Kawakami, Shigeru
    Hashida, Mitsuru
    PHARMACEUTICAL RESEARCH, 2011, 28 (07) : 1500 - 1519
  • [33] Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
    Wassana Wijagkanalan
    Shigeru Kawakami
    Mitsuru Hashida
    Pharmaceutical Research, 2011, 28 : 1500 - 1519
  • [34] Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations
    Jie Shen
    Guang Wei Lu
    Patrick Hughes
    Pharmaceutical Research, 2018, 35
  • [35] Anatomical basis of drug delivery to the inner ear
    Glueckert, R.
    Chacko, L. Johnson
    Rask-Andersen, H.
    Liu, W.
    Handschuh, S.
    Schrott-Fischer, A.
    HEARING RESEARCH, 2018, 368 : 10 - 27
  • [36] Optimization of new anxiolytic drug formulations on the basis of pharmacokinetic researches
    Zherdev, VP
    Kolyvanov, GB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S174 - S175
  • [37] POLYMORPHIC DRUG OXIDATION - PHARMACOKINETIC BASIS AND COMPARISON OF EXPERIMENTAL INDEXES
    JACKSON, PR
    TUCKER, GT
    LENNARD, MS
    WOODS, HF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (05) : 541 - 550
  • [38] PHARMACOKINETIC BASIS OF DRUG SIDE-EFFECTS IN ELDERLY PATIENTS
    CHEYMOL, G
    BIOUR, M
    THERAPIE, 1983, 38 (05): : 475 - 484
  • [39] PHARMACOKINETIC PROPERTIES OF THE NEWER CEPHALOSPORINS - A VALID BASIS FOR DRUG SELECTION
    NOBLE, JT
    BARZA, M
    DRUGS, 1985, 30 (03) : 175 - 181
  • [40] EFFECT OF INTRAVENOUS TUBING LUMEN DIAMETER ON DRUG DELIVERY
    ARWOOD, LL
    CORDERO, L
    VISCONTI, JA
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1984, 7 (04): : 259 - 262